Mutation of smeRv renders Stenotrophomonas maltophilia resistant to first-line antibiotics trimethoprim/sulfamethoxazole and levofloxacin

14 Oct 2025
0

Mutation of smeRv renders Stenotrophomonas maltophilia resistant to first-line antibiotics trimethoprim/sulfamethoxazole and levofloxacin

Boonyong N, Charoenlap N, Tipanyo P, Grittanaanun P, Mongkolsuk S, Vattanaviboon P*

Antibiotics. 2025;14:550.

Tags

Share this

Related Posts

Thongdee, P.; Hanwarinroj, C.; Pakamwong, B.; Kamsri, P.; Punkvang, A.; Leanpolchareanchai, J.; Ketrat, S.; Saparpakorn, P.; Hannongbua, S.; Ariyachaokun, K.; Suttisintong, K.; Sureram, S.; Kittakoop, P.; Hongmanee, P.; Chanthammachat, P.; Mukamolova, G.; Blood, R.; Takebayashi, Y.; Spencer, J.; Mulholland, A,; Pungpo, P. Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity. J. Chem. Inf. Model. 2022, DOI: 10.4155/fmc-2022-0124

Recent Posts